Teva announced the launch of Dexmethylphenidate HCl Extended-Release Capsules in a new 20mg strength, the generic of Novartis' Focalin XR. Focalin XR is indicated for use in attention deficit ...

SHANGHAI, June 16, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the National Medical Products Administration (NMPA) has officially accepted its New ...

Credit: Getty Images. Azstarys consists of serdexmethylphenidate, a prodrug of dexmethylphenidate, co-formulated with immediate-release dexmethylphenidate. The Food and Drug Administration (FDA) has ...

June 2, 2005 — The U.S. Food and Drug Administration (FDA) has approved extended-release dexmethylphenidate HCl capsules for once-daily treatment of attention deficit/hyperactivity disorder in adults, ...

Please provide your email address to receive an email when new articles are posted on . Impax Laboratories recently announced the FDA approval and launch of its ...

Par Pharmaceutical Companies, Inc. today announced that it has begun shipping dexmethylphenidate hydrochloride (HCl) 15 mg and 30 mg extended-release (ER) capsules CII following approval by the U.S.

TORONTO, Dec. 7, 2010 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), today announced that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food ...

NORTH WALES, Pa. – Teva has introduced a generic version of a drug used to treat attention deficit hyperactivity disorder, the company said Thursday. The drug maker announced the launch of ...